Clinical course of haemodialysis patients with malignancies and dose-adjusted chemotherapy | Zendy

Benjamin Boesler | Zendy; David Czock | Zendy; Frieder Keller | Zendy; Martin Grießhammer | Zendy; Thomas Seufferlein | Zendy; Wölfram Karges | Zendy; Franz Maximilian Rasche | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical course of haemodialysis patients with malignancies and dose-adjusted chemotherapy

Author(s) -

Benjamin Boesler,

David Czock,

Frieder Keller,

Martin Grießhammer,

Thomas Seufferlein,

Wölfram Karges,

Franz Maximilian Rasche

Publication year - 2005

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfh807

Subject(s) - medicine , chemotherapy , dose , dialysis , pharmacokinetics , retrospective cohort study , hemodialysis , surgery , oncology

Chemotherapy is not given routinely to patients with malignancies receiving chronic haemodialysis because evidence of a clear benefit is still lacking and severe side effects are feared. The aim of our retrospective study was to analyse the methods of dose adjustment and the clinical course of chronic haemodialysis patients with malignancies treated by chemotherapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research